Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000080255-25-000618
Filing Date
2025-09-08
Accepted
2025-09-08 13:35:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5825
  Complete submission text file 0000080255-25-000618.txt   7641
Mailing Address P.O. BOX 89000 BALTIMORE MD 21289
Business Address 1307 POINT STREET BALTIMORE MD 21231 (410)345-2000
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) CIK: 0000080255 (see all company filings)

EIN.: 520556948 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
(CF Office: 09 Crypto Assets)

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-38071 | Film No.: 251299456
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)